Dolby Laboratories, Inc.Class A DLB

Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.

Con 17 acciones de DLB (USD 1.005,21) habrías recibido USD 24,48 en dividendos en los últimos 12 meses.

• Zacks Investment Research 1 sept

  Zacks Industry Outlook Highlights Sony, Dolby Laboratories and Sonos

  The Audio-Video Production industry faces macroeconomic headwinds, intense competition, and margin pressures, but technological advances in 4K, 8K, immersive audio, and AI-driven workflows present growth opportunities. Sony, Dolby, and Sonos are positioned to benefit from investments in cutting-edge technology and direct-to-consumer channels, though near-term prospects remain challenging with the industry ranked in the bottom 17% of Zacks industries.

  

• Zacks Investment Research 31 ago

  3 Audio Video Stocks to Watch as the Industry Grapples With Headwinds

  The Zacks Audio Video Production industry faces macroeconomic headwinds and intense competition from low-cost importers, pressuring margins and consumer demand. However, technological advances in 4K, 8K, immersive audio, and AI-driven workflows present growth opportunities. Key players Sony, Dolby, and Sonos are positioned to benefit from streaming, gaming, creator economy trends, and automotive audio expansion.

  

• The Motley Fool 31 jul

  Why Dolby Labs Stock Popped Today

  Dolby Laboratories stock surged 11.7% after reporting mixed Q3 2026 results, beating earnings estimates ($0.69 vs $0.67 expected) but missing on revenue ($305M vs $312M expected). Despite year-over-year declines and weak GAAP earnings of $0.30 per share, the company projects strong Q4 growth and full-year guidance. However, the analyst views the stock spike as an exit opportunity, citing low single-digit growth rates that don't justify the current 21.5x P/E valuation.